Gibson, Rosemary & Prasad Singh, Janardan (2010), The Treatment Trap,
Chicago: Ivan R. Dee.
This new book discusses how the overuse of medical care is “wrecking your health and what you can do to prevent it”. Link to more information on the book and an interview with the author Rosemary Gibson.
See links below for more Notable Books
(newest to oldest)
Whoriskey, Peter – The Washington Post Special Report “Can Medical Research Be Trusted?”
- “Rising painkiller addiction shows damage from drugmakers’ role in shaping medical opinion” December 30, 2012
- “Antidepressants to treat grief? Psychiatry panelists with ties to drug industry says yes” December 26, 2012
- “As drug industry’s influence over research grows, so does the potential for bias” November 24, 2012
- “Medicare overspending on anemia drug” August 9, 2012
- “Anemia drugs made billions, but at what cost?” July 19, 2012
- “The rise and fall of a billion-dollar drug” July 19, 2012
Friedman, Richard A. “A Call for Caution on Antipsychotic Drugs.” The New York Times, September 24, 2012
Silverman, Ed. “J&J Deal With The States ‘Is Huge’: Friede Explains.” Pharmalot, September 6, 2012
Wolston, Maran (2011). An MS Patient Loses Trust When She Finds Out Her Doctor is Paid by Drug Companies. Health Affairs, 30. No.12(2011) 2449-2452.
Spurling, Geoffrey K. et. al. “Information from Pharmaceutical Companies and the Quality, Quantity, and Cost of Physicians’ Prescribing: A Systematic Review,” PLoS Medicine, (Oct.19, 2010)
Campbell E.G., R.L. Gruen, J. Mountford, L.G. Miller, P.D. Cleary, and D. Blumenthal (2007) “A National Survey of Physician-Industry Relationships.” New England Journal of Medicine. 356: 1742-1750.
Chimonas, Susan, Troyen A. Brennan, and David J. Rothman (2007) “Physicians and Drug Representatives: Exploring the Dynamics of the Relationship.” Society for General Internal Medicine. 22:184-190.
Fugh-Bernman, Adriane and Shahram Ahari (2007) “Following the Script: How Drug Reps Make Friends and Influence Doctors.” PLoS Medicine. 4(4): 0621-0625.
Oldani, Michael (2007) “Can Doctors Take Back the Script? Understanding the Total System of Prescription Generation.” Atrium: The Report of the Northwestern Medical Humanities and Bioethics Program. Summer, Issue 4: 15-17, 28.
Zipkin DA, and M.A. Steinman (2005) “Interactions Between Pharmaceutical Representatives and Doctors in Training.
A Thematic Review.” J Gen Intern Med. 20(8):7.
Mitzik, Natalie and Robert Jacobson (2004) “Are Physicians ‘Easy Marks’? Quantifying the Effects of Detailing and Sampling on New Prescriptions.” Management Science. 50(12): 1704-1715.
Oldani, Michael (2004) “Thick Prescription: Toward an Interpretation of Pharmaceutical Sales Practices.” Medical Anthropology Quarterly. 18(3): 325-356.
Dana, Jason and George Loewenstein (2003) “A Social Science Perspective on Gifts to Physicians from Industry.” JAMA. 290(2): 252-255.
Katz, Dana, Arthur L. Caplan and Jon F. Merz (2003) “All Gifts Large and Small.” American Journal of Bioethics. 3(3): 39-46.
Wazana, Ashley (2000) “Physicians and the Pharmaceutical Industry: Is a Gift Ever Just a Gift?” JAMA. 283(3): 373-380.
Chew, Lisa D., Theresa S. O’Young, Thomas K. Hazlet, Katherine A. Bradley, Charles Maynard, and Daniel S. Lessler (2000) “A Physician Survey of the Effect of Drug Sample Availability on Physicians’ Behavior.” J Gen Intern Med. 15(7): 478-483.
Lexchin J. (1993) “Interactions Between Physicians and the Pharmaceutical Industry: What Does the Literature Say?” CMAJ. 149(10):1401-7.
McKinney W.P., D. Schiedermayer, N. Lurie, D. Simpson, J. Goodman, and E. Rich (1990) “Attitudes of Internal Medicine Faculty and Residents Toward Professional Interaction with Pharmaceutical Sales Representatives.” JAMA. 264(13):1693-1697.
(newest to oldest)
Carlat, Daniel (2010) Unhinged: The Trouble with Psychiatry – A Doctor’s Revelations about a Profession in Crisis. New York: Free Press.
Petersen, Melody (2009) Our Daily Meds: How the Pharmaceutical Companies Transformed Themselves Into Slick Marketing Machines and Hooked the Nation on Prescription Drugs. New York: Farrar, Straus, and Giroux.
Brody, Howard (2007) Hooked: Ethics, the Medical Profession, and the Pharmaceutical Industry. New York: Rowman and Littlefield Publishers, Inc.
Petryna, Adriana, Andrew Lakoff, and Arthur Kleinman (2006) Global Pharmaceuticals: Ethics, Markets, Practices. Durham: Duke University Press.
Weber, Leonard (2006) Profits Before People? Ethical Standards and the Marketing of Prescription Drugs. Bloomington: Indiana University Press.
Goozner, Merrill (2005) The $800 Million Pill: The Truth Behind the Cost of New Drugs. Berkeley: University of California Press.
Kassirer, Jerome P. (2005) On The Take: How Medicine’s Complicity With Big Business Can Endanger Your Health. New York: Oxford University Press.
Santoro, Michael and Thomas M. Gorrie, eds. (2005) Ethics and the Pharmaceutical Industry. New York: Cambridge University Press.
Avorn, Jerry (2004) Powerful Medicines: The Benefits, Risks, and Costs of Prescription Drugs. New York: Alfred A. Knopf.
Angell, Marcia (2004) The Truth About the Drug Companies: How They Deceive Us and What to Do About It. New York: Random House.
Silverman, Milton and Philip R. Lee (1974) Pills, Profits, and Politics. Berkeley: University of California Press.